Mein Warenkorb

Nucleocapsid protein

Nucleocapsid protein Molekülinformation

Englischer NameNucleocapsid proteinsAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2Target-AliasNucleocapsid Proteins
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameNucleocapsid proteins
Target-AliasNucleocapsid Proteins
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

Nucleocapsid protein Molekülhintergrund

The nucleocapsid (NP) protein of Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) is encoded by the S segment of its tripartite RNA genome. NP plays a central role in viral replication by encapsidating the genomic RNA and forming ribonucleoprotein complexes with the polymerase. It is highly conserved among SFTSV strains and strongly immunogenic, making it a major target for diagnostic assays and serological studies. Because of its abundance and stability, recombinant NP is widely used as an antigen for ELISA, rapid tests, and antibody development against this emerging tick-borne phlebovirus.

Nucleocapsid protein Molekülalias

Nucleocapsid protein,NP,Protein N

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
ZelicapavirEDP-938; EP-023938Phase 2 ClinicalEnanta Pharmaceuticals IncRespiratory Syncytial Virus Infections
Details
PF-07923567RV-299; PF-07923567Phase 1 ClinicalReviral LtdRespiratory Syncytial Virus Infections
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns